Status:
COMPLETED
Efficacy of Mydriatic Drops in Premature Infants
Lead Sponsor:
Bulent Ecevit University
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
32-34 years
Brief Summary
Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care ...
Detailed Description
Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants. Met...
Eligibility Criteria
Inclusion
- Infants who were first ROP examinations
- infants born before 32 weeks.
Exclusion
- Developmental ocular and/or systemic anomalies.
- Drug use that can affect vital values
- Unstable general condition
- Food intolerance
- Recurrent vomiting.
Key Trial Info
Start Date :
January 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03448640
Start Date
January 15 2016
End Date
December 15 2017
Last Update
February 28 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.